Angeles Mecate-Zambrano

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages

B. Obermayer, F. Heppner, M. Landthaler, 2022, European Respiratory Journal.

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro

S. Ludwig, Jing Tang, L. Brunotte, 2021, British journal of pharmacology.

Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development

S. Ludwig, L. Brunotte, A. Mecate-Zambrano, 2021, Vaccines.

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine

S. Ludwig, L. Brunotte, U. Rescher, 2020, bioRxiv.

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro

S. Ludwig, Jing Tang, L. Brunotte, 2020, bioRxiv.

Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function

A. Mellmann, S. Ludwig, V. Wixler, 2021, Journal of Virology.

SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids

H. Schöler, T. Rauen, S. Ludwig, 2021, bioRxiv.